Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for NATR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -2.776M
March 31, 2026 -2.48M
December 31, 2025 -8.499M
September 30, 2025 -1.683M
June 30, 2025 -1.35M
March 31, 2025 -1.11M
December 31, 2024 -2.195M
September 30, 2024 -1.736M
June 30, 2024 -3.351M
March 31, 2024 -3.689M
December 31, 2023 -1.248M
September 30, 2023 -4.483M
June 30, 2023 -2.422M
March 31, 2023 -2.325M
December 31, 2022 -2.898M
September 30, 2022 -0.973M
June 30, 2022 -2.239M
March 31, 2022 -1.518M
December 31, 2021 -1.986M
September 30, 2021 -1.728M
June 30, 2021 -1.915M
March 31, 2021 -0.983M
December 31, 2020 -1.418M
September 30, 2020 -1.277M
June 30, 2020 -1.001M
Date Value
March 31, 2020 -1.209M
December 31, 2019 -0.628M
September 30, 2019 -1.70M
June 30, 2019 -2.387M
March 31, 2019 -0.387M
December 31, 2018 -0.902M
September 30, 2018 1.226M
June 30, 2018 0.376M
March 31, 2018 -0.489M
December 31, 2017 -1.613M
September 30, 2017 -0.755M
June 30, 2017 1.353M
March 31, 2017 -2.189M
December 31, 2016 -3.603M
September 30, 2016 -3.337M
June 30, 2016 -3.294M
March 31, 2016 -1.298M
December 31, 2015 -3.244M
September 30, 2015 -4.46M
June 30, 2015 -6.166M
March 31, 2015 -4.722M
December 31, 2014 -6.937M
September 30, 2014 -8.205M
June 30, 2014 -6.945M
March 31, 2014 -4.587M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Cyanotech Corp. -0.059M
Mannatech, Inc. -0.01M
Natural Alternatives International, Inc. -1.10M
USANA Health Sciences, Inc. -4.057M
LifeVantage Corp. -1.037M